NasdaqCM - Nasdaq Real Time Price USD
Psyence Biomedical Ltd. (PBMWW)
As of 1:49 PM EDT. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
Operating Expense
46,694.4540
46,694.4540
3,234.8690
1,855.9473
Operating Income
-46,694.4540
-46,694.4540
-3,234.8690
-1,855.9473
Net Non Operating Interest Income Expense
-50.8070
-50.8070
1.5540
--
Other Income Expense
-4,413.7860
-4,413.7860
26.9120
-2.2876
Pretax Income
-51,159.0470
-51,159.0470
-3,206.4030
-1,858.2349
Net Income Common Stockholders
-51,159.0480
-51,159.0480
-3,206.4030
-1,858.2349
Diluted NI Available to Com Stockholders
-51,159.0480
-51,159.0480
-3,206.4030
-1,858.2349
Total Expenses
46,694.4540
46,694.4540
3,234.8690
1,855.9473
Net Income from Continuing & Discontinued Operation
-51,159.0480
-51,159.0480
-3,206.4030
-1,858.2349
Normalized Income
-45,865.9180
-45,865.9180
-3,233.3150
-1,855.9473
Interest Income
2.1340
2.1340
1.5540
--
Interest Expense
52.9410
52.9410
--
--
Net Interest Income
-50.8070
-50.8070
1.5540
--
EBIT
-51,106.1060
-51,106.1060
-3,206.4030
-1,855.9473
EBITDA
-51,105.8660
-51,105.8660
-3,206.4030
-1,855.9473
Reconciled Depreciation
0.2400
0.2400
--
--
Net Income from Continuing Operation Net Minority Interest
-51,159.0480
-51,159.0480
-3,206.4030
-1,858.2349
Total Unusual Items Excluding Goodwill
-5,293.1300
-5,293.1300
26.9120
-2.2876
Total Unusual Items
-5,293.1300
-5,293.1300
26.9120
-2.2876
Normalized EBITDA
-45,812.7360
-45,812.7360
-3,233.3150
-1,853.6597
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DWTX Dogwood Therapeutics, Inc.
3.8100
-3.54%
LIPO Lipella Pharmaceuticals Inc.
0.4950
+1.09%
CYCC Cyclacel Pharmaceuticals, Inc.
1.4900
+12.88%
NRXBF NUREXONE BIOLOGIC INC
0.4000
+2.56%
NKGNW NKGen Biotech, Inc.
0.0405
-1.22%
OKUR OnKure Therapeutics, Inc.
18.50
-0.27%
SLXN Silexion Therapeutics Corp
0.4013
+19.27%
MDXXF Pharmala Biotech Holdings Inc.
0.1251
-10.64%
CDT Conduit Pharmaceuticals Inc.
0.1101
+3.62%
NWRN.SW Newron Pharmaceuticals S.p.A.
9.00
+0.45%